You think a CR would end SP growth? What about the company running out of cash? Which is worse for SP growth? They've got debt to pay and product to build. A cash infusion via a CR may not be worst thing to happen. I'd rather they don't do a CR, but if they have to then so be it.
BUD Price at posting:
2.7¢ Sentiment: Buy Disclosure: Held